Authors
James C Glasbey, Dmitri Nepogodiev, Joana FF Simoes, Omar Omar, Elizabeth Li, Mary L Venn, PGDME, Mohammad K Abou Chaar, Vita Capizzi, Daoud Chaudhry, Anant Desai, Jonathan G Edwards, Jonathan P Evans, Marco Fiore, Jose Flavio Videria, Samuel J Ford, Ian Ganly, Ewen A Griffiths, Rohan R Gujjuri, Angelos G Kolias, Haytham MA Kaafarani, Ana Minaya-Bravo, Siobhan C McKay, Helen M Mohan, Keith J Roberts, Carlos San Miguel-Méndez, Peter Pockney, Richard Shaw, Neil J Smart, Grant D Stewart, Sudha Sundar, MRCOG, Raghavan Vidya, Aneel A Bhangu, COVIDSurg Collaborative
Publication date
2021/1/1
Journal
Journal of Clinical Oncology
Volume
39
Issue
1
Pages
66-78
Publisher
American Society of Clinical Oncology
Description
PURPOSE
As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway.
PATIENTS AND METHODS
This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with …
Scholar articles
JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li… - Journal of Clinical Oncology, 2021
COVIDSurg Collaborative - Journal of Clinical Oncology, 2021